Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_2589_Библиотеки_им_академика_М_И_Перельмана
.pdf
10.7 Non-infectious Choroiditis andRetinitis
https://t.me/medicina_free
249
adjuvants. Without adjuvants, injecting soluble
retinal antigens fails to produce uveitis. The
potential antigens include retinal-S antigen,
interphotoreceptor-binding protein, recoverin,
and melanin. Immunization with all these
antigens has led to the development of autoimmune uveitis in animal models. Melanin proteins
have been used to create a rat model of CD4+
T-cell- driven experimental autoimmune uveitis
that mimics the pathology of SO [250].
The retinal-S antigen has been the most potential antigen studied of all the putative antigens,
but its antibodies have not been detected in the
sera of all SO patients [251].
Pathology ofSympathetic Ophthalmia
The pathology of SO was rst described by Dalen
and later by Fuchs as nodular aggregates beneath
the RPE layer and essentially consist of macrophages. In the late stages, the macrophages may
be accompanied by degenerated RPE cells and a
few lymphocytes. However, these nodules are
present only in one-third of the pathology samples of SO [251]. The choroid is thickened and
inltrated with lymphoid cells, epithelioid cells,
and multinucleated giant cells. The iris likewise
shows nodular inltration with lymphoid cells,
multinucleated giant cells, and epithelioid cells.
The nodular collection of epithelioid cells under
the RPE corresponds to the points of leakage on
FFA from the RPE.On electron microscopy, the
separation of tight junctions of RPE over the
Dalen Fuchs nodules has also been seen [252]. In
both sympathetic ophthalmia and VKH, despite
heavy inltration of the choroid with inammatory cells, RPE and choriocapillaris are preserved. It was suggested that the RPE might
modulate inammation in these conditions and
preserve the retina [253].
The mechanism of vision loss in SO remained
unexplained as the retina is not primarily involved
in SO. However, immune co-localization of
TNF-α and its receptor inducible nitric synthase
(iNOS) and the oxidative products nitrotyrosine
have been localized to the photoreceptors of SO
eyes explaining the apoptosis and photoreceptor
cell death following oxidative stress in SO [254].
Clinical Picture ofSympathetic
Ophthalmia
All patients who suffer from penetrating trauma
should be counselled on reporting any symptoms
in the contralateral eye for the early detection of
SO. For several generations, SO has been
described in the textbooks as a bilateral granulomatous pan uveitis that presents with mutton fat
keratic precipitates, inammatory cells in the
anterior chamber, or the vitreous cavity has been
misleading. Yellow-white lesions may be seen in
the retinal periphery if ocular media permits.
There may be papillitis, optic atrophy, retinal
vasculitis, and retinal detachment. This description ts in with the stage of chronic recurrent
uveitis. This description has led to ignoring the
earliest presentation of the SO in the earliest
stages, i.e. the acute uveitic stage.
Early Symptoms ofSympathetic
Ophthalmia
The earliest symptoms in the sympathizing eye
may be mild pain, blurred vision, and loss of
accommodation. The signs include optic disc
oedema, yellow-white discrete lesions deep to
the retina, and multifocal serous retinal detachment (Fig.10.21) [255].
In our tertiary care centre, we saw 40 patients
with SO from 1989 to 2004, 75% of whom followed trauma and 25% followed surgery. Except
for four cases, all presented in the acute stage of
the disease. More than 50% of the sympathizing
eyes presented only with posterior segment signs
and had no anterior segment inammation. There
was mild vitreous inammation in 75%, exudative
retinal detachment in 73%, yellow-white peripheral lesions in 35%, optic disc oedema in 37%, and
peripapillary CNV in 5% of the sympathizing
eyes. All four patients who presented with a
chronic stage of SO had sunset glow fundus and
discrete white scars in the retina. FFA ndings
were similar to that seen in the VKH disease and
were noted in 85% of the eyes. These consisted of
delayed choroidal lling, pinpoint hyperuorescence, and late pooling of the dye (Fig.10.21). All
15 eyes that showed optic disc oedema showed
optic disc staining on FFA. On ultrasonography,

250
hi
a
bc
https://t.me/medicina_free
10 Retinal andChoroidal Infections andInammation
d
e
f
g
j
k
Fig. 10.21 (a–g): A 24-year-old man reported sustaining
an open globe zone II injury in the right eye 2days after
hammering a chisel (a). Visual acuity was light perception
in the right eye and 6/6in the left eye. He underwent a
primary repair. Twenty days later, he returned with multifocal retinal detachments in the left eye without any
inammatory reaction (b). FFA showed an initial hypo-
uorescent pinpoint lesions which became hyperuorescent and pooled dye in late frames (c–e). USG showed
choroidal thickening (f) and OCT showed subretinal uid
with septa (g). He was treated with intravenous methylprednisolone followed by oral corticosteroids. (h–k) A
week later, his retinal detachment had resolved (g, h).
Nine-month follow-up mild pigmentary changes (i, j)

10.7 Non-infectious Choroiditis andRetinitis
https://t.me/medicina_free
251
63% of the eyes (12 of the 19 eyes) showed diffuse
thickening of the choroid. The OCT was done in
10 eyes, and in all, it showed serous retinal detachment. Ten eyes were enucleated for histopathology, and all showed granulomatous inltration of
the choroid, with eosinophilic inltration in four
eyes and retinal perivascular inltrates in one eye.
The patients were treated with aggressive corticosteroid therapy and immunomodulatory therapy.
Seventy- three percent of the eyes achieved nal
visual acuity of 6/12 or better in a median followup of 5years. Thirty percent of the sympathizing
eyes showed a severe granulomatous anterior uveitis recurrence on corticosteroid tapering. Notably,
5% of the eyes showed posterior segment recurrence in the form of exudative retinal detachment
[256].
Similarity ofSympathetic Ophthalmia
andtheAcute Uveitic Stage ofVKH
Disease
The clinical picture of the acute stage of SO and the
acute uveitic stage of the VKH disease are similar.
The FFA in patients with SO is identical to those
with VKH disease. The FFA is characterized by
focal delayed choroidal lling and multifocal pinpoint dye leakage with late dye pooling in VKH
disease and SO. Several cases of SO have been
described in the past that showed similarity between
the clinical features (vitiligo, poliosis, dysacusis,
and meningitis-like symptoms) between the SO and
the VKH disease [117, 118, 257]. The exciting eye
was enucleated and subjected to histopathology in
four SO patients who developed vitiligo, poliosis,
dysacusis, and/or meningitis mimicking complete
VKH disease. All the eyes revealed histopathological features of granulomatous choroiditis with chorioretinal adhesions and pigment migration into the
retina and features also seen in the VKH eyes [258].
The only differentiating feature of SO from VKH is
the history of penetrating trauma in the former.
Enucleation oftheInjured Eye toPrevent
Sympathetic Ophthalmia Is aMyth
The eye that undergoes trauma or surgery is termed
the exciting eye, and the contralateral eye that
develops granulomatous inammation is termed
the sympathizing eye. Both eyes show similar
granulomatous pathology, except the injured eye
also shows changes resulting from trauma. While
nearly 50% of the eyes who have developed SO do
so within 2weeks to 3months of injury, more than
90% of SO develop it in the rst year. The rule of
thumb is no longer valid, with little evidence that
SO can be prevented in the contralateral eye if the
traumatized eye is removed within 2weeks. The
SO may still happen despite the enucleation of the
inciting eye [259]. The shortest interval between
the traumatic event and the onset of SO has been
5days [260]. Not only does the removal of the eye
not exclude the risk of SO, but with the current
surgical techniques, it is possible to put together
even the badly injured eyes.
Moreover, even if the SO develops, powerful
therapeutic drugs are now available to control
and limit the damage in the sympathizing eye. If
the injured eye is badly mutilated and the surgeon
feels that anatomical integrity cannot be restored,
then instead of enucleation with its psychological
trauma and phantom pain, it should be eviscerated to allow for the implantation of a movable
prosthesis [259]. Evisceration does not appear to
increase the risk of SO.In one large series, not a
single case of SO developed following evisceration of the 491 traumatized eyes [261].
10.7.3 Organ-Specic (Ocular)
Immune-Mediated Disorders
Widely known as ‘white dot syndrome’, this is a
group of disorders characterized by discreet white
lesions deep in the retina, often bilateral, and often
seen in young to middle-aged women. The salient
clinical and imaging features of each of these disorders are given in Box 10.11. There is no anterior
segment inammation, although some have mild
vitreous inammation. Most of them cause photopsia or blurring of vision and scotomas. The
availability of multimedia imaging tools has made
it possible to differentiate them. The pathogenesis
is unknown, but there is evidence of primary choriocapillaris involvement and loss of outer retinal
microstructures. Differential diagnoses in the
white dot syndromes include sarcoidosis, TB,
syphilis, and primary vitreoretinal lymphoma,
which may have clinical presentation indistinguishable from these syndromes and need to be

252
https://t.me/medicina_free
10 Retinal andChoroidal Infections andInammation
Box 10.11 Organ-Specic (Ocular) Immune- Mediated Inammations
Disorder Clinical characteristics Imaging studies
MEWDS
1. Young women > men
2. Photopsia, blurring of vision
3. Unilateral
4. Optic disc oedema
5. Macular granularity
6. Multifocal white lesions in
paramacular and peripheral fundus
7. Spontaneous resolution in ~8weeks
FFA:
1. Hyperuorescent dots (<100μ), in wreath
conguration
2. OD staining
3. Minimum staining of white dots
ICG: Hypouorescent dots (>200μ) in late frames
FAF: Hyperautouorescent
OCT: Hyperreective lesions cantered on the
a
ellipsoid zone protruding from RPE into outer
nuclear layer
OCTA: Flow voids in CC
All changes reversible on healing
APMPPE
b
1. Young, preceding u
2. Sudden loss of vision, photopsia,
scotomas
3. Sequential bilateral creamy placoid
lesions in outer retina
4. Lesions heal spontaneously with
pigmentary changes
FFA: Initial hypouorescent, late
hyperuorescence
ICG: Hypouorescent throughout
FAF: Hypoautouorescent with a ring of
hyperautouorescence
OCT: Hyperreective material in the outer retina,
disruption of EZ and IZ; SRF+
OCTA: Flow void in CC
All changes reversible on healing except
transmission defects on FFA
c
PIC
1. Young, myopic women
2. Blurring, photopsia, metamorphopsia
3. Discrete, 100-300μ multifocal outer
retina and inner choroidal lesions in
macula, heal with punched-out
atrophic scars
4. Subfoveal haemorrhage
5. Serous macular RD
FFA: Hyperuorescence in early and late frames;
Type 2 CNV hyperuorescence in macula
ICG: Hypouorescent lesion throughout
FAF: Hyperautouorescence
OCT: Hyperreective lesions in inner choroid
with conical RPE elevation, with intact BM,
photoreceptors not visible in active lesions
OCTA: CNV between RPE and neurosensory
retina
d
IMFC
(MFC
with panuveitis)
1. Young myopic women
2. Photopsia, scotomas
3. Unilateral/bilateral/sequential
4. Multifocal choroiditis lesions or scars
5. Vitreous cells
6. Recurrent, progressive
7. CNV
FFA: Non-contributory in acute stage. Some
hyperautouorescence in late frames. Transmission
defects in scars. Type 2 CNV
ICG: Hypolesions from 50 to 400μ, most remain
hypouorescent in late frames
FAF: Hyperautouorescence
OCT: Hyperreective material in the inner choroid
elevating the RPE, with a rupture at the peak of
BM/RPE and material extending into outer retina.
Disruption of EZ, IZ, and ELM increased light
transmission through the lesion
OCTA: CC ow voids reversible in smaller lesions
d, e
AZOOR
1. Young to middle-aged healthy women
2. Moving photopsia-lightening in a
thunderstorm, photophobia, scotoma,
blind spot in temp eld, visual eld
loss, night vision problems
3. Bilateral asymmetric disease
4. Peripapillary normal or subtle lesion,
white demarcation line between
normal and affected retina may be
prominent but transient; trizonal
lesions are diagnostic
FFA: Non-contributory in acute, window defect in
late stage
ICG: Non-contributory in acute, trizonal pattern
FAF: Patch hyperautouorescence, progressive,
later hypoautouorescence, hyperautouorescent
demarcation line; normal outside the demarcation
line
OCT: Loss of EZ, thickening of outer plexiform
layer and loss of outer nuclear layer; foveal centre
may be spared for a long time loss of RPE in late
stages
5. Bone specule pigment and atrophy

10.8 Multiple Evanescent White Dot Syndrome (MEWDS)
https://t.me/medicina_free
Disorder Clinical characteristics Imaging studies
f, g
BCR
AMN
h,i
1. Middle-aged, F>M, Caucasians
2. HLA-A29*02in >95%
3. Blurring of vision or oaters both eyes
4. Creamy oval/streak lesions choroidal
500–1500μ radial to optic disc
5. Vitritis
6. CME
7. Retinal vasculitis
8. ODE
9. Cellophane maculopathy
1. Young women
2. Unilateral or bilateral Paracentral
scotomas after u-like illness,
transient or permanent
3. Fundus shows multiple reddish brown,
sharp petaloid lesions deep in the
retina centred around foveal centre
4. >100μ outer retinal changes are often
permanent
FFA: delayed A-V transit; hypolesions in the early
and mild hyperuorescence in late frames; late OD
staining; CME, retinal perivenous staining and
leakage
ICG: Most sensitive tool, hypouorescent lesions
corresponding to creamy lesions aligned with
choroidal vessels.
FAF: Linear hypoautouorescence along retinal
vessels
OCT: Disruption of ellipsoid zone, focal to
generalized; outer retinal atrophy
ERG: Full eld and mfERG shows delayed
implicit time and decreased amplitude
NIR imaging: Shows hyporeective sharply
dened lesions in the macula
FFA: Normal
ICG: Normal
FAF: Normal
OCT: Loss of ellipsoid zone/IZ and thinning of
outer nuclear layer and OPL hyperreectivity
OCTA: Flow decit in deep capillary plexiform
layer. Flow may reverse but OCT changes may not
revert
VF: Paracentral scotoma
253
MEWDS multiple evanescent white dot
syndrome, FFA fundus uorescein angiography, ICG indocyanine angsiography, FA F fundus autouorescence, OCT optical coherence
tomography, OCTA optical coherence tomography angiography, OD optic disc, CC choriocapillaris, PIC punctate inner choroidopathy,
RD retinal detachment, CNV choroidal neovascular membrane, IMFC idiopathic multifocal choroidopathy, RPE retinal pigment
epithelium, BM Bruch’s membrane, EZ ellipsoid zone, IZ interdigitating zone, ELM exter-
excluded. Except for MFC and AZOOR, which
require corticosteroids and immunosuppressive
therapy, most white dot syndromes resolve spontaneously with or without residual changes.
10.8 Multiple Evanescent White
Dot Syndrome (MEWDS)
Multiple evanescent white dot syndrome
(MEWDS) is a rare disorder usually seen in
young myopic women who present with photop-
nal limiting membrane, AZOOR acute zonal
occult outer retinopathy, BCR birdshot chorioretinopathy, ERG electroretinography, mfERG
multifocal ERG, AMN acute macular neuroretinitis, NIR near infrared, OPL outer plexiform layer
References
a
Marsiglia etal. [262]; b Testi etal. [263]; c
Ahnood et al. [264]; d Pichi et al. [202]; e
Mrejen et al. [265]; f Minos et al. [266]; g
Fogel-Levin etal. [267];
h
Yzer etal. [268]; i
Fawzi etal. [269]
sia and blurring vision (Fig.10.22). The fundus
examination reveals unilateral optic disc oedema
and multiple white lesions in the paramacular
and retinal periphery. The FAF imaging is highly
diagnostic of MEWDS (Fig. 10.23). Most of
these white dot syndromes have hyperautouorescence due to exposure of the pigments in the
RPE layer due to loss of the overlying photoreceptors and their pigments, which normally block
the autouorescence signals from the RPE [267].
Changes are reversible to a large extent in
MEWDS (Fig.10.23g).

254
b
https://t.me/medicina_free
a
10 Retinal andChoroidal Infections andInammation
Fig. 10.22 A 39-year-old man presented with oaters in
left eye for one week, with history of viral fever a few
months ago. His visual acuity was 6/6/ in both eyes. Visual
eld testing revealed enlargement of blind spot (red
a
e
b
f
Fig. 10.23 Same patient with MEWDS as in Fig.10.22,
showing fundus photographs (a, b). Fluorescein angiography shows wreath-like pattern (blue arrows) (c, d). Fundus
autouorescence shows normal right eye (e) and characteristic hyperautouorescent changes in left (f) eye.
arrow) in left eye (a). Right eye was normal (b). Imaging
revealed a diagnosis of MEWDS. (Images courtesy of Dr.
Padmamalini Mahendradas, Uveitis and Ocular Oncology,
Narayana Nethralya, Bangalore, India)
c
d
g
Follow-up at 6months reveals near complete recovery of
autouorescence ndings (g). (Images courtesy of Dr.
Padmamalini Mahendradas, Uveitis and Ocular Oncology,
Narayana Nethralya, Bangalore, India)

10.9 Acute Posterior Multifocal Placoid Pigment Epitheliopathy (APMPPE)
https://t.me/medicina_free
255
10.9 Acute Posterior Multifocal
Placoid Pigment
Epitheliopathy (APMPPE)
Acute posterior multifocal placoid pigment epitheliopathy (APMPPE) is characterized by the
a
c
sudden onset of vision loss in young women preceded by a u-like illness. It is usually bilateral,
but the other eye may have sequential involvement within a few days of the onset. The fundus
examination reveals multifocal creamy white
placoid lesions in the outer retina (Fig. 10.24).
b
d
e
Fig. 10.24 Acute posterior multifocal placoid pigment
epitheliopathy (APMPPE) in a 24-year-old man who had
viral fever 8days ago. There are asymmetric bilateral choroiditis lesions, with right eye (a) affected less than left
eye (b). FFA shows hypouorescent lesions in early phase
f
(c), which become hyperuorescent in late phase (d). A
few weeks later, the choroiditis lesions resolved completely (e, f). (Images courtesy of Dr. Padmamalini
Mahendradas, Uveitis and Ocular Oncology, Narayana
Nethralya, Bangalore, India)

256
https://t.me/medicina_free
10 Retinal andChoroidal Infections andInammation
The lesions heal by restoring the photoreceptors’
integrity and return of vision [262, 263, 270].
Many inammatory diseases, autoimmune vasculitis, infections, and vaccines have been
reported preceding the onset of APPMPPE [271].
A signicantly higher frequency of HLA-B7, a
class I antigen, and HLA-DR2, a class II antigen,
has been reported in APMPPE patients with a
relative risk of 3.38 and 3.34, respectively, lending support to a suggestion that this disorder may
be caused by underlying immune mechanisms
[272].
10.10 Punctate Inner
Choroidopathy
andIdiopathic Multifocal
Choroidopathy (PIC
andIMFC)
Most experts believe that punctate inner choroidopathy (PIC) and idiopathic multifocal choroiditis (IMFC) represent a spectrum of diseases.
Idiopathic multifocal choroidopathy has been
named in the past with various eponyms, including pseudo-presumed ocular histoplasmosis syndrome, multifocal choroiditis with panuveitis,
and multifocal inner choroidopathy. Both of
these disorders get complicated by the development of choroidal neovascular membranes
(CNV) [202, 264]. The acute lesions of IMFC
and PIC get picked up by the FAF imaging.
10.11 Acute Zonal Occult Outer
Retinopathy (AZOOR)
The symptoms of moving photopsia, ‘lightning
strike in a thunderstorm’, are highly suggestive of
acute zonal occult outer retinopathy (AZOOR).
They should prompt fundus autouorescence
studies as the fundus in the initial stages may
look normal. A trizonal pattern of autouorescence is highly characteristic of AZOOR [265].
Late stages of AZOOR result in retinal atrophy,
bone-corpuscle pigmentation in the affected
quadrants, and optic atrophy. These need to be
differentiated from autoimmune retinopathies,
retinal degenerations, and dystrophies like retinitis pigmentosa and optic neuropathies [265].
10.12 Birdshot Chorioretinopathy
(BCR)
Birdshot chorioretinopathy (BCR) is strongly
associated with HLA-A29*02in Caucasians and
rarely if ever, seen in Asians or Blacks. The diagnosis of BCR is often delayed due to very subtle
clinical lesions that may be missed in a routine
examination and need a high index of suspicion
for making an early diagnosis. Patients are highly
symptomatic even in the presence of normal or
near-normal vision. It is a chronic recurrent
inammatory disease and needs
immunosuppressive therapy to prevent retinal
atrophy and optic atrophy [266, 267].
10.13 Acute Macular Neuroretinitis
(AMN)
Acute macular neuroretinitis (AMN) is rare and
often seen in young to middle-aged women. It
often follows a u-like illness or even a sudden
hypotension attack may precipitate this disorder.
While the fundus lesions may be very subtle,
near-infrared imaging shows hyporeective
changes centred around the fovea. There are two
types of AMN, type 1, also termed paracentral
acute middle maculopathy (PAMM) due to occlusion of the deep capillary plexus and results in
hyperreectivity of the inner nuclear zone and
the outer plexiform layer and type 2, which is
characterized by the loss of outer nuclear layer
and hyperreectivity of the outer plexiform layer.
Optical coherence tomography angiography
shows ow voids in the deep retinal capillary
plexus [273, 274]. The PAMM or AMN lesions
may follow sickle cell disease [275].

References
https://t.me/medicina_free
257
References
1. Isaacs A, Lindenmann J, Valentine RC.Virus interference. II.Some properties of interferon. Proc R Soc
Lond B Biol Sci. 1957, 147;(927):268–73. https://
doi.org/10.1098/rspb.1957.0049. PMID: 13465721;
Burke DC 2009. http://www.brainimmune.com/the- -
discovery- of- interferon- the- rst- cytokine- by- alickisaacs- and- jean- lindenmann- in- 1957/.
2. di Giovine FS, Duff GW. Interleukin 1: the rst
interleukin. Immunol Today. 1990;11(1):13–20.
https://doi.org/10.1016/0167- 5699(90)90005- t.
PMID: 2405873.
3. Ferreira VL, Borba HH, de F. Bonetti A, Leonart
PL, Pontarolo R. Cytokines and interferons: types
and functions. In: Khan WA, editor. Autoantibodies
and cytokines [internet]. London: IntechOpen;
2018 [cited 2022 Oct 19]. https://doi.org/10.5772/
intechopen.74550. https://www.intechopen.com/
chapters/59914.
4. Gupta A.Bench to bedside research in ophthalmology in biomedical translational research: from disease diagnosis to treatment. In: Sobti RC, Ganju AK,
editors. vol II.Springer Nature; 2022. p.67–124.
5. Jawad S, Liu B, Agron E, Nussenblatt RB, Sen
HN. Elevated serum levels of interleukin-17A
in uveitis patients. Ocul Immunol Inamm.
2013;21(6):434–9. https://doi.org/10.3109/0927
3948.2013.815786. Epub 2013 Aug 19. PMID:
23957503; PMCID: PMC5569243.
6. Kuiper JJ, Mutis T, de Jager W, de Groot-Mijnes
JD, Rothova A.Intraocular interleukin-17 and proinammatory cytokines in HLA-A29-associated
birdshot chorioretinopathy. Am J Ophthalmol.
2011;152(2):177–182.e1. https://doi.org/10.1016/j.
ajo.2011.01.031. Epub 2011 May 13. PMID:
21570674.
7. Ooi KG, Galatowicz G, Calder VL, Lightman
SL. Cytokines and chemokines in uveitis: is there
a correlation with clinical phenotype? Clin Med
Res. 2006;4(4):294–309. https://doi.org/10.3121/
cmr.4.4.294. PMID: 17210978; PMCID:
PMC1764804.
8. Dinarello CA. Historical insights into cytokines.
Eur J Immunol. 2007;37 Suppl 1(Suppl 1):S34–45.
https://doi.org/10.1002/eji.200737772. PMID:
17972343; PMCID: PMC3140102.
9. Jabs DA, Nussenblatt RB, Rosenbaum JT,
Standardization of Uveitis Nomenclature (SUN)
Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the
rst international workshop. Am J Ophthalmol.
2005;140(3):509–16. https://doi.org/10.1016/j.
ajo.2005.03.057. PMID: 16196117; PMCID:
PMC8935739.
10. Balasundaram MB, Andavar R, Palaniswamy
M, Venkatapathy N. Outbreak of acquired ocular toxoplasmosis involving 248 patients. Arch
Ophthalmol. 2010;128(1):28–32. https://doi.
org/10.1001/archophthalmol.2009.354. Erratum
in: Arch Ophthalmol 2010 Apr;128(4):508. PMID:
20065213.
11. Robert-Gangneux F, Dardé ML. Epidemiology
of and diagnostic strategies for toxoplasmosis.
Clin Microbiol Rev. 2012;25(2):264–96. https://
doi.org/10.1128/CMR.05013- 11. Erratum in:
Clin Microbiol Rev. 2012 Jul;25(3):583. PMID:
22491772; PMCID: PMC3346298.
12. Acharya NR, Tham VM, Esterberg E, Borkar
DS, Parker JV, Vinoya AC, Uchida A. Incidence
and prevalence of uveitis: results from the Pacic
Ocular Inammation Study. JAMA Ophthalmol.
2013;131(11):1405–12. https://doi.org/10.1001/
jamaophthalmol.2013.4237. PMID: 24008391.
13. Engelhard SB, Patel V, Reddy AK. Intermediate
uveitis, posterior uveitis, and panuveitis in the midAtlantic USA. Clin Ophthalmol. 2015;9:1549–55.
https://doi.org/10.2147/OPTH.S89428. PMID:
26345421; PMCID: PMC4556262.
14. Henderly DE, Genstler AJ, Smith RE, Rao
NA.Changing patterns of uveitis. Am J Ophthalmol.
1987;103(2):131–6. https://doi.org/10.1016/s0002- -
9394(14)74217- 5. PMID: 3812615.
15. Merrill PT, Kim J, Cox TA, Betor CC, McCallum
RM, Jaffe GJ. Uveitis in the southeastern United
States. Curr Eye Res. 1997;16(9):865–74. https://
doi.org/10.1076/ceyr.16.9.865.5048. PMID:
9288447.
16. Rodriguez A, Calonge M, Pedroza-Seres M, Akova
YA, Messmer EM, D’Amico DJ, Foster CS.Referral
patterns of uveitis in a tertiary eye care center.
Arch Ophthalmol. 1996;114(5):593–9. https://
doi.org/10.1001/archopht.1996.01100130585016.
PMID: 8619771.
17. Jones JL, Holland GN. Annual burden of ocular toxoplasmosis in the US. Am J Trop Med
Hyg. 2010;82(3):464–5. https://doi.org/10.4269/
ajtmh.2010.09- 0664. PMID: 20207874; PMCID:
PMC2829910.
18. Bodaghi B, Cassoux N, Wechsler B, Hannouche D,
Fardeau C, Papo T, Huong DL, Piette JC, LeHoang
P. Chronic severe uveitis: etiology and visual outcome in 927 patients from a single center. Medicine
(Baltimore). 2001;80(4):263–70. https://doi.
org/10.1097/00005792- 200107000- 00005. PMID:
11470987.
19. Sengün A, Karadağ R, Karakurt A, Saricaoğlu
MS, Abdik O, Hasiripi H. Causes of uveitis
in a referral hospital in Ankara, Turkey. Ocul
Immunol Inamm. 2005;13(1):45–50. https://
doi.org/10.1080/09273940590909121. PMID:
15804769.
20. Al Dhahri H, Al Rubaie K, Hemachandran S, Mousa
A, Gikandi PW, Al-Mezaine HS, Abu El-Asrar
AM. Patterns of uveitis in a University-based
Tertiary Referral Center in Riyadh, Saudi Arabia.
Ocul Immunol Inamm. 2015;23(4):311–9. https://
doi.org/10.3109/09273948.2014.939197. Epub
2014 Jul 24. PMID: 25058456.

258
https://t.me/medicina_free
10 Retinal andChoroidal Infections andInammation
21. Al-Mezaine HS, Kangave D, Abu El-Asrar
AM. Patterns of uveitis in patients admitted to a
University Hospital in Riyadh, Saudi Arabia. Ocul
Immunol Inamm. 2010;18(6):424–31. https://doi.
org/10.3109/09273948.2010.502284. Epub 2010
Aug 25. PMID: 20735294.
22. Çakar Özdal MP, Yazici A, Tüfek M, Öztürk
F.Epidemiology of uveitis in a referral hospital in
Turkey. Turk J Med Sci. 2014;44(2):337–42. https://
doi.org/10.3906/sag- 1302- 132. PMID: 25536746.
23. Hamade IH, Elkum N, Tabbara KF. Causes of
uveitis at a referral center in Saudi Arabia. Ocul
Immunol Inamm. 2009;17(1):11–6. https://
doi.org/10.1080/09273940802491850. PMID:
19294567.
24. Jones JL, Bonetti V, Holland GN, Press C, Sanislo
SR, Khurana RN, Montoya JG. Ocular toxoplasmosis in the United States: recent and remote infections. Clin Infect Dis. 2015;60(2):271–3. https://doi.
org/10.1093/cid/ciu793. Epub 2014 Oct 9. PMID:
25301214.
25. Kazokoglu H, Onal S, Tugal-Tutkun I, Mirza
E, Akova Y, Ozyazgan Y, Soylu M, Batioglu
F, Apaydin C. Demographic and clinical features of uveitis in tertiary centers in Turkey.
Ophthalmic Epidemiol. 2008;15(5):285–93. https://
doi.org/10.1080/09286580802262821. PMID:
18850464.
26. Llorenç V, Mesquida M, Sainz de la Maza M, Keller
J, Molins B, Espinosa G, Hernandez MV, GonzalezMartín J, Adán A. Epidemiology of uveitis in a
Western urban multiethnic population. The challenge
of globalization. Acta Ophthalmol. 2015;93(6):561–
7. https://doi.org/10.1111/aos.12675. Epub 2015
Feb 15. PMID: 25683136.
27. Mercanti A, Parolini B, Bonora A, Lequaglie Q,
Tomazzoli L. Epidemiology of endogenous uveitis
in north-Eastern Italy. Analysis of 655 new cases.
Acta Ophthalmol Scand. 2001;79(1):64–8. https://
doi.org/10.1034/j.1600- 0420.2001.079001064.x.
PMID: 11167291.
28. Rothova A, Buitenhuis HJ, Meenken C, Brinkman
CJ, Linssen A, Alberts C, Luyendijk L, Kijlstra
A.Uveitis and systemic disease. Br J Ophthalmol.
1992;76(3):137–41. https://doi.org/10.1136/
bjo.76.3.137. PMID: 1540555; PMCID:
PMC504190.
29. Sittivarakul W, Bhurayanontachai P, Ratanasukon
M.Pattern of uveitis in a university-based referral
center in southern Thailand. Ocul Immunol Inamm.
2013;21(1):53–60. https://doi.org/10.3109/0927394
8.2012.730651. PMID: 23323582.
30. Soheilian M, Heidari K, Yazdani S, Shahsavari M,
Ahmadieh H, Dehghan M. Patterns of uveitis in
a tertiary eye care center in Iran. Ocul Immunol
Inamm. 2004;12(4):297–310. https://doi.
org/10.1080/092739490500174. PMID: 15621869.
31. Das D, Bhattacharjee H, Bhattacharyya PK, Jain L,
Panicker MJ, Das K, Deka AC.Pattern of uveitis in
North East India: a tertiary eye care center study.
Indian J Ophthalmol. 2009;57(2):144–6. https://doi.
org/10.4103/0301- 4738.45506. PMID: 19237790;
PMCID: PMC2684416
32. Biswas J, Narain S, Das D, Ganesh SK. Pattern
of uveitis in a referral uveitis clinic in India.
Int Ophthalmol. 1996;20(4):223–8. https://doi.
org/10.1007/BF00175264. PMID: 9112191.
33. Rathinam SR, Namperumalsamy P. Global variation and pattern changes in epidemiology of uveitis. Indian J Ophthalmol. 2007;55(3):173–83.
https://doi.org/10.4103/0301- 4738.31936. PMID:
17456933.
34. Biswas J, Kharel Sitaula R, Multani P. Changing
uveitis patterns in South India—comparison between
two decades. Indian J Ophthalmol. 2018;66(4):524–
7. https://doi.org/10.4103/ijo.IJO_851_17. PMID:
29582812; PMCID: PMC5892054.
35. Dogra M, Singh R, Agarwal A, Sharma A, Singh
SR, Gautam N, Yangzes S, Samanta R, Sharma M,
Aggarwal K, Sharma A, Sharma K, Bansal R, Gupta
A, Gupta V.Epidemiology of uveitis in a TertiaryCare Referral Institute in north India. Ocul Immunol
Inamm. 2017;25(sup1):S46–53. https://doi.org/10.
1080/09273948.2016.1255761. Epub 2016 Dec 12.
PMID: 27937033.
36. Singh R, Gupta V, Gupta A. Pattern of uveitis
in a referral eye clinic in North India. Indian J
Ophthalmol. 2004;52(2):121–5. PMID: 15283216.
37. Venkatesh P, Gogia V, Shah B, Gupta S, Sagar P, Garg
S.Patterns of uveitis at the Apex Institute for Eye
Care in India: results from a prospectively enrolled
patient data base (2011-2013). Int Ophthalmol.
2016;36(3):365–72. https://doi.org/10.1007/s10792- -
015- 0128- 9. Epub 2015 Sep 25. PMID: 26408195.
38. Furtado JM, Smith JR, Belfort R Jr, Gattey D,
Winthrop KL. Toxoplasmosis: a global threat.
J Glob Infect Dis. 2011;3(3):281–4. https://doi.
org/10.4103/0974- 777X.83536. PMID: 21887062;
PMCID: PMC3162817.
39. Smith JR, Ashander LM, Arruda SL, Cordeiro
CA, Lie S, Rochet E, Belfort R Jr, Furtado
JM. Pathogenesis of ocular toxoplasmosis. Prog
Retin Eye Res. 2021;81:100882. https://doi.
org/10.1016/j.preteyeres.2020.100882. Epub 2020
Jul 24. PMID: 32717377.
40. Harker KS, Ueno N, Lodoen MB.Toxoplasma gondii dissemination: a parasite’s journey through the
infected host. Parasite Immunol. 2015;37(3):141–
9. https://doi.org/10.1111/pim.12163. PMID:
25408224.
41. Varikuti S, Jha BK, Holcomb EA, McDaniel JC,
Karpurapu M, Srivastava N, McGwire BS, Satoskar
AR, Parinandi NL. The role of vascular endothelium and exosomes in human protozoan parasitic diseases. Vessel Plus. 2020;4:28. https://doi.
org/10.20517/2574- 1209.2020.27. Epub 2020 Sep
27. PMID: 33089078; PMCID: PMC7575144.
42. Furtado JM, Bharadwaj AS, Chipps TJ, Pan Y,
Ashander LM, etal. Toxoplasma gondii tachyzoites
cross retinal endothelium assisted by intercellular
Соседние файлы в папке Библиотека им академика М.И. Перельмана
